Radiotherapy News and Research

RSS
Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
Fibrous scars drive glioblastoma recurrence

Fibrous scars drive glioblastoma recurrence

Major funding boost aims to advance research on bone metastasis in breast and prostate cancers

Major funding boost aims to advance research on bone metastasis in breast and prostate cancers

Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders

Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders

New imaging technology enhances detection of tumor remnants

New imaging technology enhances detection of tumor remnants

UQ study unlocks potential for advanced bladder cancer immunotherapy

UQ study unlocks potential for advanced bladder cancer immunotherapy

Total neoadjuvant therapy shows promising results in routine care for advanced rectal cancer

Total neoadjuvant therapy shows promising results in routine care for advanced rectal cancer

New treatment for rectal cancer offers hope in avoiding surgery

New treatment for rectal cancer offers hope in avoiding surgery

Olaparib effective against BRCA2-mutated prostate cancer

Olaparib effective against BRCA2-mutated prostate cancer

UQ research could lead to a more effective treatment for bladder cancer

UQ research could lead to a more effective treatment for bladder cancer

AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatment

AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatment

New targets for improved cancer immunotherapy

New targets for improved cancer immunotherapy

Key insights on diagnosis and treatment of cardiac sarcomas

Key insights on diagnosis and treatment of cardiac sarcomas

Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma

Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma

Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

Radiotherapy after surgery shown to prevent breast cancer recurrence for up to 10 years

Radiotherapy after surgery shown to prevent breast cancer recurrence for up to 10 years

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

FDA approves vorasidenib for Grade 2 gliomas with IDH mutations

FDA approves vorasidenib for Grade 2 gliomas with IDH mutations

Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes

Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

Breakthrough X-ray-sensitizers could revolutionize radiotherapy for cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.